Business Wire07.29.20
MedX Health Corp. has appointed medical equipment industry executive Nick Hoffman as director, Business Development, effective immediately. Hoffman will be working with the MedX team in managing customer acquisition and support initiatives as the company commercializes and begins an aggressive installation phase for its SIAscopy on DermSecure telemedicine platform.
“Nick brings years of experience in healthcare sales, marketing and service management, working with start-ups and industry leading OEM’s scaling revenue and building partnerships,” noted Scott Spearn, CEO of MedX. “We will be scaling rapidly as the demand for telemedicine and remote assessment applications have come to the forefront, and working with customers and practitioners to implement our unique dermatologic platform, Nick’s success in serving customer needs will be important in this next phase of our growth.”
Hoffman has spent most of his career in the healthcare diagnostic imaging industry, including roles with radiology, teleradiology and digital imaging companies in product support, product sales management, business strategy, business development and marketing. He has proven expertise in assisting companies through start-up to revenue generation, product sales and distribution and value creation at companies such as, Johnson & Johnson, GE Healthcare, Siemens Healthcare, and a variety of university-based startup companies.
Currently, between 2 million and 3 million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation Statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.
“Nick brings years of experience in healthcare sales, marketing and service management, working with start-ups and industry leading OEM’s scaling revenue and building partnerships,” noted Scott Spearn, CEO of MedX. “We will be scaling rapidly as the demand for telemedicine and remote assessment applications have come to the forefront, and working with customers and practitioners to implement our unique dermatologic platform, Nick’s success in serving customer needs will be important in this next phase of our growth.”
Hoffman has spent most of his career in the healthcare diagnostic imaging industry, including roles with radiology, teleradiology and digital imaging companies in product support, product sales management, business strategy, business development and marketing. He has proven expertise in assisting companies through start-up to revenue generation, product sales and distribution and value creation at companies such as, Johnson & Johnson, GE Healthcare, Siemens Healthcare, and a variety of university-based startup companies.
Currently, between 2 million and 3 million non-melanoma skin cancers and 300,000 melanoma skin cancers occur globally each year. One in every three cancers diagnosed is a skin cancer and, according to Skin Cancer Foundation Statistics, one in every five people will develop skin cancer in their lifetime. The global demand for SIAscopy on DermSecure will continue to increase with the growth of telemedicine and as early detection is recognized as the way to optimize survival and reduce healthcare costs.